Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04248452
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:10.155944+00:00
Published At
2026-03-23T00:00:00+00:00
Record Updated At
2026-03-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clinical Stage IV Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IV Gastric Cancer AJCC v8", "Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IVA Gastric Cancer AJCC v8", "Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IVB Gastric Cancer AJCC v8", "Metastatic Esophageal Adenocarcinoma", "Metastatic Gastric Adenocarcinoma", "Oligometastatic Esophageal Adenocarcinoma", "Oligometastatic Gastric Adenocarcinoma", "Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IV Gastric Cancer AJCC v8", "Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-23"
protocolSection.identificationModule.nctId
"NCT04248452"
protocolSection.identificationModule.officialTitle
"A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IV Gastric Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IVA Gastric Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IVB Gastric Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Metastatic Esophageal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Gastric Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Oligometastatic Esophageal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Oligometastatic Gastric Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV Gastric Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.